Your browser is no longer supported. Please, upgrade your browser.
Settings
ORGO [NASD]
Organogenesis Holdings Inc.
Index- P/E21.44 EPS (ttm)0.46 Insider Own94.00% Shs Outstand128.55M Perf Week0.81%
Market Cap1.27B Forward P/E21.35 EPS next Y0.47 Insider Trans-0.87% Shs Float62.68M Perf Month-6.66%
Income61.70M PEG0.35 EPS next Q0.13 Inst Own42.90% Short Float11.96% Perf Quarter-37.58%
Sales446.30M P/S2.85 EPS this Y136.40% Inst Trans9.61% Short Ratio6.59 Perf Half Y-44.20%
Book/sh1.47 P/B6.77 EPS next Y12.29% ROA18.40% Target Price24.00 Perf Year94.34%
Cash/sh0.80 P/C12.46 EPS next 5Y61.34% ROE36.80% 52W Range4.56 - 24.34 Perf YTD32.14%
Dividend- P/FCF35.97 EPS past 5Y199.90% ROI12.60% 52W High-59.05% Beta1.34
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin76.00% 52W Low118.53% ATR0.59
Employees910 Current Ratio2.60 Sales Q/Q12.90% Oper. Margin16.20% RSI (14)36.57 Volatility5.21% 5.60%
OptionableYes Debt/Eq0.44 EPS Q/Q-51.30% Profit Margin13.80% Rel Volume0.42 Prev Close9.95
ShortableYes LT Debt/Eq0.38 EarningsNov 09 AMC Payout0.00% Avg Volume1.14M Price9.97
Recom1.20 SMA20-8.05% SMA50-17.52% SMA200-36.83% Volume258,271 Change0.15%
Jan-10-20Initiated SVB Leerink Outperform $9
Aug-26-19Resumed Credit Suisse Outperform $9 → $10
May-02-19Initiated Credit Suisse Outperform $9
Apr-17-19Initiated Oppenheimer Outperform $11
Apr-11-19Initiated SunTrust Buy $11
Nov-28-21 08:57AM  
Nov-27-21 05:00AM  
Nov-26-21 05:50PM  
Nov-24-21 06:39PM  
Nov-22-21 10:20AM  
07:00AM  
04:22AM  
Nov-21-21 08:57AM  
Nov-20-21 10:54AM  
Nov-19-21 10:35AM  
Nov-18-21 06:39PM  
10:15AM  
Nov-17-21 11:30PM  
03:04PM  
Nov-16-21 06:31PM  
Nov-15-21 03:36PM  
Nov-14-21 10:29AM  
Nov-12-21 06:06PM  
10:25AM  
Nov-11-21 06:39PM  
10:00AM  
Nov-10-21 06:38PM  
09:55AM  
09:01AM  
Nov-09-21 06:31PM  
06:25PM  
04:05PM  
Nov-08-21 10:00AM  
07:30AM  
Nov-07-21 08:57AM  
Nov-05-21 07:15PM  
09:35AM  
Nov-04-21 06:39PM  
05:50PM  
09:35AM  
02:46AM  
Nov-03-21 06:38PM  
02:57PM  
Nov-02-21 06:31PM  
03:02PM  
11:38AM  
Nov-01-21 04:35PM  
04:29PM  
09:39AM  
Oct-31-21 08:57AM  
Oct-29-21 06:54PM  
05:52PM  
05:50PM  
02:55PM  
Oct-28-21 06:39PM  
10:46AM  
Oct-27-21 06:38PM  
09:25AM  
Oct-26-21 06:31PM  
06:10PM  
03:00PM  
01:02AM  
Oct-25-21 06:11PM  
04:26PM  
03:00PM  
01:47PM  
12:15PM  
09:51AM  
Oct-24-21 08:57AM  
Oct-22-21 06:54PM  
Oct-21-21 06:39PM  
06:30PM  
09:30AM  
Oct-20-21 07:27PM  
06:38PM  
04:00PM  
02:51PM  
09:25AM  
Oct-19-21 06:31PM  
Oct-18-21 08:17PM  
Oct-17-21 08:57AM  
Oct-15-21 09:00PM  
08:46PM  
06:54PM  
05:57PM  
12:00PM  
Oct-14-21 06:35PM  
02:22PM  
09:49AM  
Oct-13-21 06:20PM  
06:18PM  
03:00PM  
01:40PM  
01:13PM  
Oct-12-21 06:17PM  
06:11PM  
05:37PM  
05:17PM  
01:31PM  
12:21PM  
Oct-07-21 04:05PM  
Sep-10-21 09:00AM  
Sep-09-21 09:23AM  
Sep-01-21 12:20PM  
Aug-23-21 07:00AM  
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound covering and surgical barrier for application in the care of chronic and acute wounds or surgical implantation in spine, orthopedic, and sports medicine applications; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft, a dermal substitute for the treatment of DFUs; NuShield, a dehydrated placental tissue wound covering and surgical barrier applied to the target tissue to support native healing; and PuraPly Antimicrobial, an antimicrobial barrier skin substitute to treat chronic and acute wounds. Its surgical and sports medicine products comprise NuCel, a surgically implanted allograft used primarily in spinal and orthopedic surgical applications; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor, a chorionic membrane wound covering; TransCyte, a bioengineered tissue for the treatment of partial thickness burns; and Gintuit, a bioengineered bi-layered living cellular tissue for the treatment of mucogingival conditions in adults. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GN 2016 Organo 10-Year GRAT u/10% OwnerNov 18Buy9.9325,000248,25059,448,027Nov 22 08:39 PM
NUSSDORF GLENN HDirectorNov 18Buy9.9325,000248,25059,448,027Nov 22 08:39 PM
KATZ MICHAEL W10% OwnerNov 17Buy10.871,00010,87054,282Nov 19 05:03 PM
KATZ MICHAEL W10% OwnerNov 15Buy11.081,00011,08053,282Nov 19 05:03 PM
KATZ MICHAEL W10% OwnerNov 12Buy11.203,00033,60052,282Nov 19 05:03 PM
Bilbo PatrickChief Operating OfficerNov 10Option Exercise1.4430,45043,848133,670Nov 12 06:01 PM
KATZ MICHAEL W10% OwnerAug 17Buy13.5512,000162,60049,282Aug 19 07:38 PM
Gillheeney Gary S.President and CEOJul 19Option Exercise0.99160,237158,635292,154Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 19Sale14.02160,2372,246,523131,917Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 16Option Exercise3.51139,763490,488271,680Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 16Sale14.74139,7632,059,820131,917Jul 20 08:45 PM
ERANI ALBERT10% OwnerJun 09Sale15.31150,0002,296,50059,432,133Jun 10 09:33 PM
Albert Erani Family Trust date10% OwnerJun 09Sale15.31150,0002,296,50059,432,133Jun 10 09:27 PM
ERANI ALBERT10% OwnerJun 08Sale15.41100,0001,541,00059,582,133Jun 08 08:03 PM
Albert Erani Family Trust date10% OwnerJun 08Sale15.41100,0001,541,00059,582,133Jun 08 07:52 PM
ERANI ALBERT10% OwnerJun 07Sale16.1494,6121,527,03859,682,133Jun 08 08:03 PM
Albert Erani Family Trust date10% OwnerJun 07Sale16.1494,6121,527,03859,682,133Jun 08 07:52 PM
ERANI ALBERT10% OwnerJun 04Sale16.2260,000973,20059,776,745Jun 08 08:03 PM
Albert Erani Family Trust date10% OwnerJun 04Sale16.2260,000973,20059,776,745Jun 08 07:52 PM
Erani Dennis10% OwnerMay 27Sale18.979,106172,7411,314,517Jun 28 09:17 PM
NUSSDORF GLENN HDirectorMay 27Sale16.403,887,50063,755,00059,836,745May 28 09:37 PM
Ades Alan A.DirectorMay 27Sale16.403,887,50063,755,00059,836,745May 28 09:32 PM
Wisdom Starr10% OwnerApr 09Sale22.1120,000442,20020,000May 18 07:45 PM
Wisdom Starr10% OwnerMar 01Sale16.508,050132,82540,000May 18 07:45 PM
Wisdom Starr10% OwnerFeb 25Sale14.8329,335435,00848,050May 18 07:45 PM
Wisdom Starr10% OwnerFeb 24Sale14.7015,154222,76477,385May 18 07:45 PM
Gillheeney Gary S.President and CEOFeb 18Sale12.8516,663214,120139,807Feb 18 08:34 PM
Gillheeney Gary S.President and CEOFeb 17Sale13.3789,3751,194,498156,470Feb 18 08:34 PM
Wisdom Starr10% OwnerFeb 16Sale12.95170,0002,201,50092,539May 18 07:45 PM
Gillheeney Gary S.President and CEOFeb 16Sale13.12111,4061,461,647194,219Feb 16 09:57 PM
Wisdom Starr10% OwnerFeb 12Sale12.9199,9181,290,430262,539May 18 07:45 PM
Gillheeney Gary S.President and CEOFeb 12Sale13.20111,3291,469,871305,625Feb 16 09:57 PM
NUSSDORF GLENN HDirectorFeb 11Sale3.25200,000650,00068,594,976Feb 16 08:15 PM
Ades Alan A.DirectorFeb 11Sale3.25200,000650,00068,594,976Feb 16 08:12 PM
Wisdom Starr10% OwnerFeb 11Sale14.0223,840334,237362,457May 18 07:45 PM
Gillheeney Gary S.President and CEOFeb 11Sale13.8269,127955,335416,954Feb 16 09:57 PM
MACKIE WAYNE DDirectorDec 02Buy5.2638,710203,615200,000Dec 03 08:10 PM